Cover Image
市場調查報告書

中國的感染疾病診斷市場預測

China Infectious Diagnostics Market Outlook to 2021

出版商 GlobalData 商品編碼 346059
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
Back to Top
中國的感染疾病診斷市場預測 China Infectious Diagnostics Market Outlook to 2021
出版日期: 2015年08月14日 內容資訊: 英文 48 Pages
簡介

本報告提供中國的感染疾病診斷市場相關調查分析,提供您各市場區隔的收益實際成果·預測,不同分類的企業佔有率·流通佔有率,主要企業簡介等系統性資訊。

第1章 目錄

第2章 簡介

第3章 中國的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 中國的主要企業概要:感染疾病診斷市場

  • 企業概要
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Siemens Healthcare
    • Danaher Corporation
    • Alere Inc.
    • Hologic, Inc.
    • Becton, Dickinson and Company
    • Cepheid
    • Qiagen N.V.
    • DiaSorin S.p.A

第5章 感染疾病診斷市場開發中產品

第6章 財務交易形勢

  • 夥伴關係

第7章 最近的發展

  • 企業宣傳
  • 公佈財報
  • 其他重要的發展

第8章 附錄

圖表

目錄
Product Code: GDMECC1248DB

GlobalData's new report, "China Infectious Diagnostics Market Outlook to 2021", provides key market data on the China Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Infectious Diagnostics market.
  • Global corporate-level profiles of key companies operating within the China Infectious Diagnostics market.
  • Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Infectious Diagnostics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Infectious Diagnostics Market, China

  • 3.1. Infectious Diagnostics Market, China, Revenue ($m), 2007-2014
  • 3.2. Infectious Diagnostics Market, China, Revenue ($m), 2014-2021
    • 3.2.1. Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2014-2021
  • 3.3. Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 3.4. Infectious Diagnostics Market, China, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in China, Infectious Diagnostics Market

  • 4.1. F. Hoffmann-La Roche Ltd.
    • 4.1.1. Company Overview
  • 4.2. Abbott Laboratories
    • 4.2.1. Company Overview
  • 4.3. Bio-Rad Laboratories, Inc.
    • 4.3.1. Company Overview
  • 4.4. Siemens Healthcare
    • 4.4.1. Company Overview
  • 4.5. Danaher Corporation
    • 4.5.1. Company Overview
  • 4.6. Alere Inc.
    • 4.6.1. Company Overview
  • 4.7. Hologic, Inc.
    • 4.7.1. Company Overview
  • 4.8. Becton, Dickinson and Company
    • 4.8.1. Company Overview
  • 4.9. Cepheid
    • 4.9.1. Company Overview
  • 4.10. Qiagen N.V.
    • 4.10.1. Company Overview
  • 4.11. DiaSorin S.p.A
    • 4.11.1. Company Overview

5. Infectious Diagnostics Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Partnerships
    • 6.1.1. Biocartis Enters into Licensing and Development Agreement with Microbiome
    • 6.1.2. Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Dec 04, 2014: Neogen names COO
  • 7.2. Financial Announcements
    • 7.2.1. Jul 21, 2015: Neogen reports record revenues and earnings
    • 7.2.2. May 09, 2015: Shanghai MicroPort Orthopedics Hosts First SuperPath Online Symposium
    • 7.2.3. Mar 26, 2015: Neogen reports 13% increase in net income
    • 7.2.4. Dec 31, 2014: MicroPort Completes First Implantation of Reewarm18
    • 7.2.5. Dec 18, 2014: Neogen reports 26% increase in net income
    • 7.2.6. Sep 22, 2014: Neogen Reports 13% Net Income Increase
  • 7.3. Other Significant Developments
    • 7.3.1. Jun 11, 2015: Lansen subsidiary signs a distribution agreement with Bio-Rad China and expands into the clinical diagnostic market in the PRC

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Company Share Analysis
    • 8.1.5. Distribution Share Analysis
  • 8.2. GlobalData Consulting
  • 8.3. Contact Us
  • 8.4. Disclaimer

List of Tables

  • Table 1: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 5: Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 6: Infectious Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 7: Infectious Diagnostics Market Pipeline Products
  • Table 8: Biocartis Enters into Licensing and Development Agreement with Microbiome
  • Table 9: Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical

List of Figures

  • Figure 1: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 5: Infectious Diagnostics Market, China, Company Share (%) 2014
Back to Top